Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy — Olga Mucha (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
Shared by
Jozef Dulak
Jagiellonian University Cracow
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
Article
2021
en
Authors
+3 more
OM
Olga Mucha
PP
Paulina Podkalicka
KK
Katarzyna Kaziród
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Preprint
2021
Simvastatin Influences Selected Aspects of Duchenne Muscular Dystrophy Pathology in a Mouse Model
Olga Mucha
,
Paulina Podkalicka
,
Katarzyna Kaziród
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2024
432P Hydrogen sulfide attenuates skeletal muscle abnormalities in a murine model of Duchenne muscular dystrophy
Agnieszka Łoboda
,
Małgorzata Myszka
,
Olga Mucha
,
Kalina Hajok
,
Ewa Jakubczak
,
Urszula Waśniowska
,
Jozef Dulak
Article
2019
Targeting angiogenesis in Duchenne muscular dystrophy
Paulina Podkalicka
,
Olga Mucha
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2021
Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout
Olga Mucha
,
Katarzyna Kaziród
,
Paulina Podkalicka
,
Kinga Rusin
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2020
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
Agnieszka Łoboda
,
Jozef Dulak
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.